Frequency, factors and costs associated with injection site infections: Findings from a national multi-site survey of injecting drug users in England
Open accessThe DOI matches its Crossref record; 35 of the 36 references it cites were found in a registry or an index; 6 of the 70 sources its claims cite were checked for support.
Abstract
BACKGROUND: Injection site infections among injecting drug users (IDUs) have been associated with serious morbidity and health service costs in North America. This study explores the frequency, factors and costs associated with injection site infections among IDUs in England. METHODS: Unlinked-anonymous survey during 2003/05 recruiting IDUs from community settings at seven locations across England. Self-reported injecting practice, symptoms of injection site infections (abscess or open wound) and health service utilisation data were collected using a questionnaire, participants also provided dried blood spot samples (tested for markers blood borne virus infections). Cost estimates were obtained by combining questionnaire data with information from national databases and the scientific literature. RESULTS: 36% of the 1,058 participants reported an injection site infection in the last year. Those reporting an injection site infection were more likely to be female and aged over 24, and to have: injected into legs, groin, and hands in last year; injected on 14 or more days during the last four weeks; cleaned needles/syringes for reuse; injected crack-cocaine; antibodies to hepatitis C; and previously received prescribed substitute drug. Two-thirds of those with an injection site infection reported seeking medical advice; half attended an emergency department and three-quarters of these reported hospital admission. Simple conservative estimates of associated healthcare costs range from pound 15.5 million per year to as high as pound 30 million; though if less conservative unit costs assumptions are made the total may be much higher (pound 47 million). The vast majority of these costs are due to hospital admissions and the uncertainty is due to little data on length of hospital stays. CONCLUSION: Symptoms of injection site infections are common among IDUs in England. The potential costs to the health service are substantial, but these costs need more accurate determination. Better-targeted interventions to support safer injection need to be developed and evaluated. The validity of self-reported symptoms, and the relationship between symptoms, infection severity, and health seeking behaviour require further research.
Overview
CoChat Summary
TL;DR
In a 2003/05 national multi-site survey of 1,058 injecting drug users in England, 36% reported an injection site infection (abscess or open wound) in the past year. Associated healthcare costs were conservatively estimated at £15.5–30 million annually, with hospital admissions driving most of the cost.
Key findings
- 36% (385/1,058) reported an injection site infection in the previous year. In multivariate analysis, factors associated included female gender (aOR 1.7, 95% CI 1.2–2.4), age 25+ (e.g. 30–34 aOR 2.0, 1.3–3.2), injecting into leg (aOR 2.2, 1.6–3.1), groin (aOR 1.4, 1.1–1.9), or hand (aOR 1.9, 1.3–2.6), injecting on 14–27 days in the last 4 weeks (aOR 1.8, 1.2–2.9), cleaning needles/syringes for reuse (aOR 1.5, 1.1–2.1), crack-cocaine injection (aOR 1.5, 1.1–2.0), anti-HCV positivity (aOR 1.5, 1.1–2.0), and previously receiving prescribed substitute drug (aOR 1.7, 1.3–2.4).
- Among those reporting an infection, 68% (260/382) sought health care; 47% (180/381) attended an emergency department, and 78% (140/180) of those attending an emergency department were admitted to hospital.
- Annual cost estimates ranged from at least £19.2 million (low unit costs per hospital stay, 140,000 IDUs) to £30.5 million (high unit costs per hospital stay, 140,000 IDUs); using daily costs, estimates were at least £15.5 million for a 2-day stay and £20.6 million for a 4-day stay. Table 4 totals reached £46.9 million for 215,000 IDUs with high unit costs. Hospital admissions made up over 88% of total cost estimates.
- The authors estimate over 30,000 IDUs seek health care for injection site infections each year in England, with at least 18,500 admitted to hospital.
Methods
- Unlinked-anonymous community-recruited survey conducted autumn 2003–summer 2005 at seven broadly representative locations in England; 1,058 participants who had injected in the preceding 28 days completed a questionnaire on demographics, injecting practice, symptoms of injection site infection, and health service use, and provided dried blood spot samples tested for anti-HCV, anti-HBc, and anti-HIV.
- Univariable χ² analyses followed by forward stepwise logistic regression identified factors associated with reporting an injection site infection and with seeking health care for it.
- Cost estimation combined questionnaire data with NHS reference costs 2005–06 and Unit Costs of Health and Social Care 2006, scaled to IDU population estimates of 140,000 (opiate/crack injectors) and 215,000 (all IDUs), assuming one infection episode per IDU per year.
Limitations
- Stated by the paper: self-reported symptoms were used, though prior studies show good concordance with clinical diagnosis; sampling may over-represent high-risk IDUs who use needle exchanges and other recruitment settings, so cost estimates could be overestimates; cost estimates were conservative, assuming only one care episode per year, lacking UK-specific length-of-stay data, and excluding high-dependency or other high-cost care.
- Evident from the text: the cross-sectional design cannot establish causality between associated factors and injection site infections; health service use and cost inputs rely on self-report and external unit-cost assumptions, making the economic estimates exploratory.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
5 Valid · 0 Not valid · 31 Not checked · 52 Own results and interpretations
Every source the paper cites for this claim was checked and supports it.
In the paper
“with indications of increased hospital admissions related to femoral injection among IDUs [13].”
§ Frequency, factors and costs associated with injection site infections: Findings from a national multi-site survey of injecting drug users in England > Discussion
What the sources say
- Supportedcites [13] Irish C Maxwell R Dancox M Brown P Trotter C Verne J Shaw M Skin and soft tissue infections and vascular disease among drug users, England [letter] Emerg Infect Dis 2007 13 1510 1511 18257999 PMC2851502 source
In the study findings (page not supplied), admissions for femoral-vein phlebitis or thrombophlebitis rose from 60 to 533. The authors say increases in femoral-vein and lower-limb vascular conditions suggest that groin injecting may have contributed, while noting that the admissions cannot be definitively attributed to that practice. The claim's wording, “indications,” preserves that uncertainty. (LLM, conf=0.90)
hedgedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“These infections are, however, likely to place a considerable, and possibly increasing burden on health services as observed elsewhere [3-5,18].”
§ Frequency, factors and costs associated with injection site infections: Findings from a national multi-site survey of injecting drug users in England > Background
What the sources say
- Not checked yetcites [3] Darke S Ross J Kaye S Physical injecting sites among injecting drug users in Sydney, Australia Drug Alcohol Depend 2001 62 77 82 11173170 10.1016/S0376-8716(00)00161-7 source
- Partly supportedcites [4] Takahasi T Merrill J Boyko E Bradley K Type and location of injection drug use-related soft tissue infections predict hospitalization J Urban Health 2003 80 127 136 12612102 10.1007/BF02416916 PMC3456115 sourceExperimental — accuracy not yet measured
Our copy supports the 'considerable burden ... as observed elsewhere' element: the Abstract reports that 40% of IDUs seeking ED care for soft tissue infections were hospitalized, 44.3% of those stays lasted 3+ days, and 'the morbidity associated with such infections and the intensive use of hospital services needed to treat these infections' argue for preventive interventions (Abstract; Discussion, Table 3/odds of hospitalization). The 'possibly increasing' element is not this paper's own finding: the Introduction credits an increasing number of admissions for soft tissue infections between 1996 and 2000 to a separate San Francisco General Hospital medical record review, and states 'this study included all soft tissue infections, not just those related to injection drug use,' while the Discussion repeats that only 'that study' described an increase and notes 'No study has assessed rates of hospitalization or operating room procedures specifically for injection drug users.' The England extrapolation is the citing authors' own framing, and this source's data are from a US urban county hospital ED (Nov 1999–Apr 2000). (LLM, conf=0.78)
- Not checked yetcites [5] Biswanger I Kral A Bluthenthal R Rybold D Edlin B High prevalence of abscesses and cellulitis among community-recruited injection drug users in San Fransisco Clin Infect Dis 2000 30 579 581 10722447 10.1086/313703 source
- Not checked yetcites [18] Morrison A Elliott L Gruer L Injecting-related harm and treatment seeking behaviour among injecting drug users Addiction 1997 92 1349 1352 9489051 10.1111/j.1360-0443.1997.tb02853.x source
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“past studies have shown that earlier health care seeking and targeted prevention can reduce emergency department visits, hospital bed days, and surgical procedures by more than a third [37,38].”
§ Frequency, factors and costs associated with injection site infections: Findings from a national multi-site survey of injecting drug users in England > Discussion
What the sources say
- Not checked yetcites [37] Harris H Young D Organ C Jr Care of injection drug users with soft tissue infections in San Fransisco Arch Surg 2002 137 1217 1222 12413304 10.1001/archsurg.137.11.1217 source
- Partly supportedcites [38] Grau L Arevalo S Catchpool C Heimer R Expanding harm reduction services through a wound and abscess clinic Am J Public Health 2002 92 1915 1917 12453808 PMC1447352 sourceExperimental — accuracy not yet measured
The concluding passage in our copy (labeled Abstract; page unavailable) says the clinic can make more appropriate use of emergency departments by referring patients only when needed. It does not report that earlier care and targeted prevention reduced emergency department visits, hospital bed days, or surgical procedures by more than a third. (LLM, conf=0.85)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“half attended an emergency department”
- Also stated in: § Heath services use and costs · plain
“Almost half of those seeking advice for an injection site infection reported attending an emergency department (47%, 180/381)”
§ Frequency, factors and costs associated with injection site infections: Findings from a national multi-site survey of injecting drug users in England > Abstract > Results
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Heath services use and costs · plain
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“injected crack-cocaine”
- Also stated in: § Factors associated with symptoms injection site infections · plain
“| Inject crack last 4 weeks | No | 188 | 588 | 32% | 1.0 | | 1.0 | |”
- Also stated in: § Factors associated with symptoms injection site infections · plain
“| | Yes | 177 | 402 | 44% | 1.7 | 1.3 – 2.2 | 1.5 | 1.1 – 2.0 |”
§ Frequency, factors and costs associated with injection site infections: Findings from a national multi-site survey of injecting drug users in England > Abstract > Results
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Factors associated with symptoms injection site infections · plain
48 more claims
Create a free account to see all 88 claims and to verify the 64 references still open.
- Probably not a substantial claim. 28
- It may state two separate claims as one. 15
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated major: it would touch a result — a value a result rests on, reported and recomputed p-values on opposite sides of the significance level, two passages that conflict with no sign which is right, or a cited work retracted before this paper was published.
In the paper
“| Total | 19,220 | 29,516 | 30,527 | 46,881 |”
§ Frequency, factors and costs associated with injection site infections: Findings from a national multi-site survey of injecting drug users in England > Results > Heath services use and costs
Reported 46881 · recomputed 47686
Rated major: it would touch a result — a value a result rests on, reported and recomputed p-values on opposite sides of the significance level, two passages that conflict with no sign which is right, or a cited work retracted before this paper was published.
In the paper
“| Total | 19,220 | 29,516 | 30,527 | 46,881 |”
§ Frequency, factors and costs associated with injection site infections: Findings from a national multi-site survey of injecting drug users in England > Results > Heath services use and costs
Reported 30527 · recomputed 31052
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Frequency, factors and costs associated with injection site infections: Findings from a national multi-site survey of injecting drug users in England > Discussion
“The conservative cost estimate from this study – at least £15.5–19.5 million per annum –”
§ Frequency, factors and costs associated with injection site infections: Findings from a national multi-site survey of injecting drug users in England > Discussion
“These infections are preventable, yet based on conservative exploratory estimates they may cost the health service in England at least £15.5–19.2 million per annum.”
Citations
Cites
Binswanger, I. A., Kral, A. H., Bluthenthal, R. N., Rybold, D. J., & Edlin, B. R. (2000) · Clinical Infectious Diseases · doi:10.1086/313703 · Cited by 300
GRIFFITHS, P., GOSSOP, M., POWIS, B., & STRANG, J. (1993) · Addiction · doi:10.1111/j.1360-0443.1993.tb02036.x · Cited by 290 · cited 2×
“Participants were recruited either directly from a range of low threshold services, including drop-in centres and needle exchanges, or using indigenous fieldworkers to recruit from the community settings[20].”
BackgroundMethodHospital utilization and costs in a cohort of injection drug users.
(2001) · PubMed Central · Cited by 263
Risk Factors for Skin and Soft‐Tissue Abscesses among Injection Drug Users: A Case‐Control Study
Murphy, E. L., DeVita, D., Liu, H., Vittinghoff, E., Leung, P., Ciccarone, D. H., & Edlin, B. R. (2001) · Clinical Infectious Diseases · doi:10.1086/320879 · Cited by 262
Cherubin, C. E., & Sapira, J. D. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-119-10-199311150-00009 · Cited by 238
Rhodes, T., Kimber, J., Small, W., Fitzgerald, J., Kerr, T., Hickman, M., & Holloway, G. (2006) · Addiction · doi:10.1111/j.1360-0443.2006.01556.x · Cited by 230
Self-citationHigh rates of primary care and emergency department use among injection drug users in Vancouver
Kerr, T., Wood, E., Grafstein, E., Ishida, T., Shannon, K., Lai, C., Montaner, J., & Tyndall, M. W. (2005) · Journal of Public Health · doi:10.1093/pubmed/fdh189 · Cited by 201 · cited 3×
“These infections are also the most common presenting diagnoses among IDUs attending emergency departments in North America [7,8].”
BackgroundChronic illicit drug use, health services utilization and the cost of medical care
French, M. T., McGeary, K. A., Chitwood, D. D., & McCoy, C. B. (2000) · Social Science & Medicine · doi:10.1016/s0277-9536(99)00411-6 · Cited by 201
Cutaneous complications of intravenous drug abuse
Del Giudice, P. (2004) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2004.05607.x · Cited by 187
Safer Injection Facilities in North America: Their Place in Public Policy and Health Initiatives
Broadhead, R. S., Kerr, T. H., Grund, J.-P. C., & Altice, F. L. (2002) · Journal of Drug Issues · doi:10.1177/002204260203200113 · Cited by 153
Research works printed but not linked: 4
- Kearns AM Rathmann IR Holmes A Pitt TL Cookson BD An unusual clone of MRSA causing infection in injecting drug users J Infect 2004 49 49 50
- Akbulut D Dennis J Gent M Grant KA Hope V Ohai C McLauchlin J Mithani V Mpamugo O Ncube F Outbreak report: Wound botulism in injectors of illicit drugs: upsurge in cases in England during 2004 EuroSurveillance Monthly 2005 10
- National Health Service NHS reference costs 2005–06 2006 London: Department of Health
- Curtis L Netten A Unit costs of Health and Social Care 2006 Personal Social Services Research Unit Canterbury: University of Kent
Cited by
Altice, F. L., Kamarulzaman, A., Soriano, V. V., Schechter, M., & Friedland, G. H. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60829-x · Cited by 504
A systematic review of injecting-related injury and disease among people who inject drugs
Larney, S., Peacock, A., Mathers, B. M., Hickman, M., & Degenhardt, L. (2017) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2016.11.029 · Cited by 244
Self-citationIversen, J., Page, K., Madden, A., & Maher, L. (2015) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000000659 · Cited by 189
Health outcomes associated with crack-cocaine use: Systematic review and meta-analyses
Butler, A. J., Rehm, J., & Fischer, B. (2017) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2017.08.036 · Cited by 174
Dried Blood Spot for Hepatitis C Virus Serology and Molecular Testing
Tuaillon, É., Mondain, A., Meroueh, F., Ottomani, L., Picot, M., Nagot, N., de Perre, P. V., & Ducos, J. (2009) · Hepatology · doi:10.1002/hep.23407 · Cited by 161
Metadata
- Authors
- Hope, V., Kimber, J., Vickerman, P., Hickman, M., & Ncube, F.
- Affiliations
- UNSW Sydney (AU)
- London School of Hygiene & Tropical Medicine (GB)
- University of Bristol (GB)
- Corresponding author
- Hope, Vivian
- Venue
- BMC Infectious Diseases
- Published
- 2008-09-18
- Volume
- 8
- Issue
- 1
- Pages
- 120-120
- ISSN
- 1471-2334 (ISSN-L)
- PMC
- PMC2600824
- OpenAlex
- W2068816858
- Semantic Scholar
- 3b2b9c9256321d1faa780a4ebc583eefaca82d3c
- Cited by
- 112
- References
- 36
- Citations by year
- 2026: 1 · 2025: 4 · 2024: 7 · 2023: 6 · 2022: 5 · 2021: 7 · 2020: 10 · 2019: 10 · 2018: 6 · 2017: 6 · 2016: 7 · 2015: 9 · 2014: 7 · 2013: 5 · 2012: 4
- FWCI
- 4.47
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/2.0 (tdm)
- Locations
- BMC Infectious Diseases (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Explore Bristol Research (publishedVersion)
- Liverpool John Moores University (acceptedVersion)
- LSHTM Research Online (London School of Hygiene and Tropical Medicine) (acceptedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Australian Government
- National Institute for Health and Care Research
- National Health and Medical Research Council
- Topics
- Health Sciences › Medicine › Epidemiology › HIV, Drug Use, Sexual Risk
- Health Sciences › Medicine › Emergency Medicine › Intramuscular injections and effects
- Social Sciences › Cultural Studies › Tattoo and Body Piercing Complications
- Keywords
- injection site infection, people who inject drugs, health care costs, needle reuse, hepatitis C, crack cocaine, hospitalization, health care utilization, self-reported symptoms, risk factors
- MeSH terms
- Adolescent, Adult, Age Factors, Aged, Ambulatory Care, Bacterial Infections, England, Female, Hospitalization, Humans, Infections, Male, Middle Aged, Office Visits, Surveys and Questionnaires, Sex Factors, Substance Abuse, Intravenous, Health Care Costs, Drug Users
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-07, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-07 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol and qwen3.8-omni-flash).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Frequency, factors and costs associated with injection site infections: Findings from a national multi-site survey of injecting drug users in England. https://app.cochat.ai/papers/10.1186/1471-2334-8-120
- The paper
- Hope, V., Kimber, J., Vickerman, P., Hickman, M., & Ncube, F. (2008). Frequency, factors and costs associated with injection site infections: Findings from a national multi-site survey of injecting drug users in England. BMC Infectious Diseases. https://doi.org/10.1186/1471-2334-8-120
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.